Stock Options (Details) - $ / shares |
3 Months Ended | 12 Months Ended | ||
---|---|---|---|---|
Mar. 31, 2025 |
Dec. 31, 2022 |
Dec. 31, 2024 |
Mar. 31, 2024 |
|
Stock Options [Line Items] | ||||
Granted options to purchase | ||||
Stock option grant | ||||
Exercise price per share (in Dollars per share) | ||||
Unvested options | ||||
2016 Equity Incentive Plan [Member] | ||||
Stock Options [Line Items] | ||||
Granted options to purchase | 386,021 | |||
Common Stock [Member] | ||||
Stock Options [Line Items] | ||||
Stock option grant | 76,190 | |||
Exercise price per share (in Dollars per share) | $ 27.9 |
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Gross number of share options (or share units) granted during the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Number of non-vested options outstanding. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|